Immunoglobulin heavy variable 1-58 (IGHV1-58)

Immunoglobulin heavy variable 1-58 (IGHV1-58) refers to a specific gene segment encoding the variable region of the heavy chain in human immunoglobulins (antibodies)[1]. The variable region of immunoglobulin heavy chains is responsible for antigen recognition and is a critical component of the antigen-binding site, working in conjunction with the variable region of the light chain[1]. These variable domains are produced by V-(D)-J rearrangement in B lymphocytes and subjected to somatic hypermutation, allowing for diversity and affinity maturation of antibodies in the adaptive immune response[1]. IGHV1-58 is not a receptor, enzyme, or classical therapeutic target; rather, it is a gene segment involved in generating antibody diversity[1][2]. It plays a role in humoral immunity, helping the immune system to recognize and neutralize pathogens, but it is not itself a direct target of therapeutic drugs or biologics. Allelic polymorphisms within IGHV gene segments, including IGHV1-58, influence the diversity and population distribution of antibody responses[2][3]. Currently, IGHV1-58 is not associated with direct drug interactions, mechanism of drug action, or use as a clinical biomarker. **Notes:** - IGHV1-58 is not a classical “therapeutic target” (such as GPCRs, enzymes, or receptors) but is essential for antibody diversity in adaptive immunity[1][2][3]. - No specific drugs directly interact with IGHV1-58 as a molecular target, but antibodies that incorporate IGHV1-58 gene segments may be involved in immune responses against infections or other conditions[2][3]. - There are no reported major safety concerns specifically related to IGHV1-58 as a germline gene segment.

Other names

IGHV1-58IGHV158VHimmunoglobulin heavy chain variable regionImmunoglobulin heavy variable 1-58